This paper presents results of studies evaluating the efficacy of various granular formulations of VectoBac® (Bacillus thuringiensis israelensis de Barjac [Bti] H-14 strain AM65-52) against immature mosquitoes in 2 distinct habitats in Poland and Germany. Meadows intermittently flooded with sewage water in the city of Wroclaw, Poland, provide ideal habitats for immature stages of Aedes caspius, Ae. vexans, and Culex pipiens pipiens. Helicopter applications of VectoBac G and VectoBac TP sand granules (VectoBac TP-SG) at rates of 5 and 10 kg/ha to the meadows resulted in between 70.9% and 97.4% larval mortality. In Germany, some swampy woodlands in the upper Rhine Valley provide ideal habitats for snowmelt mosquitoes, Aedes cantans, Ae. punctor, Ae. rusticus, and Ae. communis. Ground applications of VectoBac G, VectoBac TP-SG, and VectoBac WG IcyPearls (VectoBac WG-IP) were made to these habitats when the water temperature was ∼7°C. Larval mortality at 7-day post-application ranged from 90.9% (VectoBac TP-SG: 10 kg/ha) to 98.0% (VectoBac WG-IP: 15 kg/ha). In a separate microcosm trial within the same habitat, all 3 granule formulations controlled larvae of Ae. cantans for 3 wk.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.